COVID-19 Vaccine Eligibility and Booking Guidelines

 

The North Durham Family Health Team is pleased to be included in the list of providers to offer COVID-19 vaccine to eligible patients. Appointments can be booked online by clicking the link below or by calling 905-985-2895 ext. 6070. We will not be accepting walk-ins at this time.

Please review eligibility criteria prior to booking your COVID-19 Vaccine appointment.

Clinics that we are currently running:

  • Moderna Bivalent B.A. 1 Vaccines for all booster doses for those 18+ years of age, according to guidelines below

  • Pfizer Bivalent B.A. 4/5 Vaccines for all booster doses for those 12+ years of age, according to guidelines below

  • Pfizer vaccines 1st and 2nd dose (primary series), according to guidelines below. Please call our office at 905-985-2895 ext. 6070 to register for your 1st or 2nd doses.

  • Children’s Pfizer Bivalent Vaccine Dates:

5 – 11-Year-old:
Thursday, February 16, 2023 – 2:00 – 4:00 p.m.

6mth – 4-Year-old:
Wednesday, February 8, 2023 – 9:45 a.m. – 12:00 p.m.
Thursday, March 2, 20239:45 a.m. – 12:00 p.m.

  • Please call our office at 905-985-2895 ext. 6070 to register for the Children’s clinics.  You can also visit the website, durhamvaccinebookings.ca to book an appointment with Durham Public Health for more frequent clinics.

Eligibility Criteria for COVID-19 Vaccines

All residents age 5 +

  • Effective, January 1, 2022, individuals must be 12 years old at time of vaccination to receive adult dose of Pfizer vaccine.
  • Children 5 to 11-years old are eligible to receive the paediatric Pfizer COVID-19 vaccine based on their birth date. Children must be at least 5 years of age at the time of immunization

NOTE: You must be the age listed at the time of immunization

  Primary Dose Series Booster Doses
Group 1st 2nd All Boosters
18+ years Week 0 8 weeks/56 days(minumum 19/21d) 168 days (6 months) from previous dose (84 days informed consent)
Pfizer  Pfizer  Moderna or Pfizer Bivalent 
12 to 17 years Week 0 8 weeks/56 days(minumum 19/21d) 168 days (6 months) from 2nd dose (84 days informed consent)
Pfizer  Pfizer  Pfizer Bivalent Preferred or Moderna Bivalent with informed consent
5 to 11 years Week 0 8 weeks/56 days(minumum  19d) 168 days (6 months) from 2nd dose (84 days informed consent)
Pediatric Pfizer Pediatric Pfizer Pediatric Pfizer
6 months to 4 years Week 0 8 weeks/56 days(minumum  28d)  
Infant Pfizer  Infant Pfizer   
Age-Based Eligibility

Who: Individuals 18 years of age and older (must be 18 years of age at the time of immunization).

Interval criteria: A minimum of 140 days after third dose. With informed consent, individuals may receive a fourth dose at a minimum of 84 days after their third (booster) dose.

First Nation, Inuit and Métis adults (must be 16 years of age or older at the time of immunization)

Who: First Nations, Inuit and Métis individuals and their non-Indigenous household members aged 18 and older.

Interval criteria: A minimum of 140 days after third dose. With informed consent, individuals may receive a fourth dose at a minimum of 84 days after their third (booster) dose.

Recipients of a viral vector vaccine or series

Who:

  • Primary series completed with only viral vector vaccines
  • Individuals who received two doses of AstraZeneca/COVISHIELD COVID-19 vaccine
  • Individuals who received one dose of Janssen/Johnson & Johnson COVID-19 vaccine

Interval criteria: A minimum of 84 days after the SECOND dose

How to receive vaccine: We are currently accepting appointment bookings for eligible patients using our online booking link above or by calling the office at 905-985-2895 ext. 6070.  Many community pharmacies and the Durham Region Health Health Department are also offering appointments.

Moderately to severely immunocompromised individuals due to medical condition

Who: Individuals 12 years of age or older (must be 12 years of age or older at time of immunization), and meet at least one of the following criteria:

  • Individuals receiving dialysis (hemodialysis or peritoneal dialysis).
  • Individuals receiving active treatment (e.g., chemotherapy, targeted therapies, immunotherapy) for solid tumour or hematologic malignancies. Active treatment includes patients who have completed treatment within 3 months.
  • Recipients of solid-organ transplant and taking immunosuppressive therapy.
  • Recipients of chimeric antigen receptor (CAR)-T-cell therapy or hematopoietic stem cell transplant (within 2 years of transplantation or taking immunosuppression therapy).
  • Individuals with moderate to severe primary immunodeficiency (e.g., DiGeorge syndrome, Wiskott-Aldrich syndrome).
  • Individuals with HIV with prior AIDS defining illness or prior CD4 count ≤ 200/mm3 or prior CD4 fraction ≤ 15%

Fourth dose interval:

  • Youth 12 to 17-years old: minimum 168 days following third dose is recommended and associated with a lower risk of myocarditis and pericarditis.
    • With informed consent, youth 12 to 17-years old may receive a booster dose at a minimum of 84 days after completion of their second dose of a 3-dose primary COVID-19 vaccine series.
  • Individuals 18 years and older: minimum 84 days following third dose.

How to receive vaccine: Before vaccination, these individuals should discuss their vaccine plans with their health care providers to check if it will affect their treatment.

Individuals receiving immunosuppressive medication

Who: Individuals 12 years of age or older (must be 12 years of age or older at time of immunization) and receiving active treatment with the following categories of immunosuppressive therapies: anti-B cell therapies* (monoclonal antibodies targeting CD19, CD20 and CD22), high-dose systemic corticosteroids (refer to the CIG for suggested definition of high dose steroids), alkylating agents, antimetabolites, or tumor-necrosis factor (TNF) inhibitors and other biologic agents that are significantly immunosuppressive.

*Active treatment for patients receiving B-cell depleting therapy includes patients who have completed treatment within 12 months.

See Table 1: List of immunosuppressive medications

Fourth dose interval:

  • Youth 12 to 17-years old: minimum 168 days following third dose is recommended and associated with a lower risk of myocarditis and pericarditis.
    • With informed consent, youth 12 to 17-years old may receive a booster dose at a minimum of 84 days after completion of their second dose of a 3-dose primary COVID-19 vaccine series.
  • Individuals 18 years and older: minimum 84 days following third dose.

Proof of eligibility requirement: Verbally attest to receiving listed immunosuppressant medications or therapies.

How to receive vaccine: Before vaccination, these individuals should discuss their vaccine plans with their health care providers to check if it will affect their treatment.

Proof of eligibility requirements: Verbally attest to receiving listed immunosuppressant medications or therapies  

Vulnerable older adults in congregate settings

Who: Residents of long-term care homes, retirement homes, elder care lodges, and older adults living in other congregate settings (e.g., assisted-living facilities, chronic care hospitals, naturally occurring congregate retirement settings/congregate senior’s apartment buildings, older adults living in congregate settings for people with developmental disabilities, mental health and addictions issues, etc.).

Fourth dose interval: Minimum 84 days following third dose.

Proof of eligibility requirement: Verbally attest to being a resident of a listed seniors congregate living setting.

How to receive vaccine: 

  • The Health Department is working with these facilities to coordinate vaccination of residents at their residence.
  • Appointments can also be booked at a community immunization clinic by visiting durham.ca/VaccineAppointment or calling the call centre at 1-888-444-5113.
By Clicking the booking link, you

COVID-19 Vaccine

Ready to book your COVID-19 vaccine? Click through below to start to process to booking an appointment with our medical staff online!